Literature DB >> 6416700

Effects of intravesical instillation of antitumor drugs on the induction of preneoplastic bladder lesions in rats.

M Ohtani, S Fukushima, N Ito, K Koiso, T Niijima.   

Abstract

The effects of adriamycin (ADR) and mitomycin C (MMC) as inhibitors of the development of bladder tumors in rats were studied. Six-week-old female F344 rats were divided into nine groups, five of which received 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in their drinking water for the first 4 weeks, no treatment for 1 week, and then intravesical instillation once a week of ADR, MMC, or physiological saline or no instillation (no catheterization) for 12 weeks. The other four groups received no BBN for the first 5 weeks of the experiment and then received ADR, MMC, or physiological saline as above for 12 weeks. The bladders were examined by light microscopy 17 weeks after the beginning of the experiment. Results showed that development of preneoplastic lesions induced in the bladders of the rats by BBN was stimulated by subsequent instillation of ADR or MMC. This result suggests that ADR and MMC have promoting activities in bladder carcinogenesis of rats.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416700     DOI: 10.1007/BF00256721

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  14 in total

Review 1.  Current therapy of bladder carcinoma.

Authors:  H B Grossman
Journal:  J Urol       Date:  1979-01       Impact factor: 7.450

2.  Surveillance, initial assessment, and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. National Bladder Cancer Collaborative Group A (NBCCGA).

Authors: 
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

3.  Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder.

Authors:  M D Banks; J E Pontes; R M Izbicki; J M Pierce
Journal:  J Urol       Date:  1977-11       Impact factor: 7.450

4.  Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.

Authors:  Y Horn; A Eidelman; N Walach; M Ilian
Journal:  J Urol       Date:  1981-05       Impact factor: 7.450

5.  The effect of mitomycin C on superficial bladder cancer.

Authors:  M S Soloway; W M Murphy; M D DeFuria; S Crooke; P Finebaum
Journal:  J Urol       Date:  1981-05       Impact factor: 7.450

Review 6.  Rationale for intensive intravesical chemotherapy for superficial bladder cancer.

Authors:  M S Soloway
Journal:  J Urol       Date:  1980-04       Impact factor: 7.450

7.  Prognostic parameters in superficial bladder cancer: an analysis of 315 cases.

Authors:  W Lutzeyer; H Rübben; H Dahm
Journal:  J Urol       Date:  1982-02       Impact factor: 7.450

8.  Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.

Authors:  S Fukushima; G Murasaki; M Hirose; K Nakanishi; R Hasegawa; N Ito
Journal:  Acta Pathol Jpn       Date:  1982-03

9.  Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  K Nakanishi; A Hagiwara; M Shibata; K Imaida; M Tatematsu; N Ito
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

10.  Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.

Authors:  G R Prout; P P Griffin; B N Nocks; M D DeFuria; J J Daly
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.